Pliant Therapeutics (PLRX) Total Liabilities (2019 - 2026)

Pliant Therapeutics (PLRX) has 8 years of Total Liabilities data on file, last reported at $37.4 million in Q1 2026.

• Total Liabilities for Q1 2026 came in at $37.4 million, down 57.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $37.4 million (down 57.27% YoY), and the FY2025 annual result was $44.0 million, down 52.6% from the prior year.
• Total Liabilities slipped to $37.4 million in Q1 2026 per PLRX's latest filing, from $44.0 million in the prior quarter.
• Over five years, Total Liabilities peaked at $99.8 million in Q3 2024 and troughed at $23.2 million in Q1 2022.
• A 5-year average of $57.9 million and a median of $41.8 million in 2023 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2022 and 2026: Total Liabilities jumped 213.83% in 2022, then sank 57.27% in 2026.
• A 5-year view of Total Liabilities shows it stood at $37.3 million in 2022, then gained by 3.51% to $38.6 million in 2023, then surged by 140.73% to $92.9 million in 2024, then slumped by 52.6% to $44.0 million in 2025, then decreased by 14.98% to $37.4 million in 2026.
• Business Quant data shows PLRX's Total Liabilities at $37.4 million in Q1 2026, $44.0 million in Q4 2025, and $76.3 million in Q3 2025.